Search Results 211-220 of 17061 for Ribosome
The RPD Pilot trial will evaluate the safety and effectiveness of Verve Medical's RPDTM renal denervation system for hypertensive patients with uncontrolled ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
The Mukhopadhyay lab at Mayo Clinic studies angiogenesis, cardiovascular disease, heart morphology, and cardiac structure and function.
Enzyme inhibitors, such as ibrutinib and ixazomib citrate, may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...
Learn about this rare type of white blood cell cancer. Treatments include chemotherapy, targeted therapy, immunotherapy and bone marrow transplant.
The overall goal of this research is to investigate potential differences in the regulation of skin blood flow in individuals with spinal cord injury.
Research in the Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., is funded by national institutions focused on regenerative ...
About this study. This is a Phase III, randomised, open-label, sponsor-blinded, 3-arm, multicentre, global study assessing the efficacy and safety of ...
This rare soft tissue cancer affects children more often than adults. Treatment may include surgery, chemotherapy and radiation therapy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.